Is BPC-157 Safe? A Full Risk Breakdown for First-Time Users
BPC-157 safety is not settled. Learn what human studies, cancer concerns, and product-quality risks mean before first use.
Snail mucin has real repair signals, but the anti-aging hype needs careful decoding before you buy.

BPC-157 safety is not settled. Learn what human studies, cancer concerns, and product-quality risks mean before first use.
Peptide eye creams can beat luxury serums when the formula supports hydration, barrier comfort, and realistic wrinkle care.
Matrixyl 3000 has real peptide science behind it, but the best claims still need context before you buy another serum.
BPC-157 has no approved human dose. Learn what common ranges, cycle lengths, and stop rules really mean.
Oral BPC-157 is convenient and injectable BPC-157 is more targeted, but neither route is proven for joint repair in high-quality human trials.
STEP 1, STEP 4 and SURMOUNT-4 show what really happens when patients stop GLP-1 peptides. Tapering, maintenance dosing, and the lifestyle handoff that protects results.
BPC-157 picked up a Marvel-superhero nickname, a podcast spotlight, and an FDA panel review — but the human evidence is still almost nonexistent.
The FDA is reconsidering BPC-157 for ulcerative colitis. Here's the gut-specific evidence map — IBD, leaky gut, IBS, ulcers — and what functional clinics actually prescribe.
Tirzepatide and semaglutide produce nearly identical weight loss across reproductive stages. Pairing GLP-1 peptides with HRT increases loss by ~30%.

Avocados, eggs, olive oil, oats, and Greek yogurt are the five foods with peer-reviewed evidence for naturally boosting GLP-1, Ozempic's hormone.
Snail mucin has real repair signals, but the anti-aging hype needs careful decoding before you buy.
The goal isn’t to be comfortable with change — it’s to be comfortable with one small change, on a schedule, held for a year.
We’re recording with NotebookLM. Expect a deep-dive and a short-form version of each issue’s best essays, delivered to your favorite podcast app when we launch.